Thursday, January 24, 2019
Text Size

IHVN Begins Project to Strengthen Pharmacovigilance

Bookmark and Share


To strengthen the monitoring and reporting of side effects of medications used to treat diseases such as multi-drug resistant tuberculosis, Institute of Human Virology Nigeria (IHVN) has begun a project titled Pharmacovigilance Africa (PAVIA) with funding from the European Developing Countries Clinical Trials Partnership (EDCTP).

In support of the project, the Institute will be training health care workers across the country on pharmacovigilance, developing necessary guidelines and carrying out research. IHVN Assistant Director Pharmacy, Mr. Yohanna Avong, who participated in the kick-off meeting for the project, says that it would build a strong pharmacovigilance system that will enable the country, “receive drugs from all over the world that can be used for the control of epidemics especially tuberculosis.”

Mr. Avong adds that the Institute will work with the National Agency for Food and Drug Administration Control (NAFDAC) and the University of Benin, who are also implementing the grant as a regulatory agency and research institution respectively.

The four year PAVIA project is being implemented in four African countries namely Ethiopia, Swaziland, Tanzania and Nigeria. Collaborative support across several institutions in Europe and Africa is being harnessed to achieve better pharmacovigilance in the implementing countries.

:: Privacy Policy

IHVN frowns at reproduction of the content of this website without prior permission.This act is illegal and punishable under the law.

:: Support and Funding

 The Institute of Human Virology, Nigeria AITRP Training     Programmes are supported and funded by the Fogarty International Center.

IHVN Member's Logon